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Background: The evaluation of exhaled breath profiles by electronic nose (eNose) is considered as
a promising non-invasive diagnostic tool, and the discrimination of breathprints between patients
with COPD and asthma has been reported. The aim of this study was to assess, whether exhaled
breath profile analysis can detect the inflammatory airway response induced by ozone inhalation.
Methods: In a randomized double-blind, cross-over study 14 healthy ozone-responsive subjects
were exposed to 250 ppb ozone and filtered room air for 3 h with intermittent exercise. Blood
biomarkers, exhaled NO, exhaled CO, and breathprints (Cyranose 320) were assessed prior and
at 3 time points up to 24 h post exposure. Induced sputum was collected at baseline and 3 h post
exposure. Multivariate analysis of eNose data was performed using transformed and normalized
datasets.
Results: Significantly increased numbers of sputum and blood neutrophils were observed after
ozone,whereas theeNose signals showednodifferences betweenexposures andnocorrelationwith
neutrophilic airway inflammation.However, independentofozoneexposure, sensordatacorrelated
with serum SP-D levels and to a smaller extent with blood neutrophil numbers.
Conclusions: Exhaled breath profiles as measured by the Cyranose 320 did not reflect airway
responses toozone.This suggests that exhaled volatiles didnot changewithozonechallengesor that
the changeswerebelowthedetection limits. Conversely, the correlation of eNose signalswith blood
neutrophils and serumSP-D, i.e.markers of systemic inflammation and lungpermeability, suggested
that the Cyranose 320 can detect volatile organic compounds of systemic origin.
ª 2011 Elsevier Ltd. All rights reserved.743704.
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Breath profiles correlate with systemic markers 1353Introduction safely and reproducibly allows to induce transient neutro-Both asthma and COPD are inflammatory diseases of the
airways.1,2 While diagnosis, monitoring and disease
management are mainly based on lung function and symp-
toms, it is believed that an efficient treatment of these
diseases should aim at a reduction of inflammation and on
drugs with anti-inflammatory action. Based on this, the
need for simple non-invasive tools to assess airway
inflammation in clinical practice is widely recognized.
The analysis of induced sputum can be considered as the
gold standard of the non-invasive methods to assess airway
inflammation. It enables the analysis of both cellular
composition and of fluid phase biomarkers. There are,
however, significant limitations, as due to the need of
mucus homogenisation not all fluid phase compounds are
readily detectable.3 In addition, the induction process is
not without risk for severely ill patients4 and can influence
sputum composition, which limits the sampling to at most
once every 48 h.3 Spontaneous sputum is produced by some
but not all patients and generally of lower quality; it is
therefore not suited for experimental studies. These
restrictions might be circumvented by using indirect
measures of inflammation, such as exhaled breath analysis.
This has been established for exhaled nitric oxide (FeNO),
a valuable tool for the detection of eosinophil-related
airway inflammation and an indicator for steroid sensi-
tivity.5 Exhaled breath condensate offers the analysis of
multiple non-volatile compounds, but is still hampered by
methodological difficulties and standardization issues.6
The analysis of volatile compounds in exhaled breath
using an electronic nose is considered as a promising non-
invasive diagnostic tool. Published data already suggest
that it is possible to discriminate breathprints of tumour
patients from those of healthy subjects7 or breathprints of
patients with COPD from those of asthma patients.8,9
Despite these results, the usefulness of the technique for
the identification of specific phenotypes of airway inflam-
mation has not been proven. In this study we addressed the
ability of the instrument Cyranose 320 to detect airway
responses to ozone inhalation. The ozone challenge modelFigure 1 Study design. Ozone exposures were performed at leas
oxide, CO: exhaled carbon monoxide, ppb: parts per billion).philic airway inflammation in healthy subjects. This
response is well known from experimental studies on air
pollution and has meanwhile been employed in proof-of-
concept studies of early drug development.10e13
Therefore the major aim of this study was to determine
whether exhaled breath profile assessed by the Cyranose
320 would be altered in response to ozone inhalation in
healthy subjects. For the sake of comparison we addition-
ally measured multiple markers in blood and serum at
different time points and explored the relationship of these
markers with the eNose signals.Material and methods
Study design
In a randomized, double-blind, two-way cross-over study,
subjects were exposed to either ozone (O3) or filtered room
air (RA) in an ozone challenge chamber (Fig. 1). Subjects
were randomized to two different sequences (RA-O3)/(O3-
RA) in a 1:1 ratio. Exposures were performed at least 14
days apart to avoid carry-over effects. Before the start,
immediately after, as well as 3 h and 21 h post exposure
exhaled air of the subjects was analyzed by eNose. In
addition, FeNO and exhaled CO were measured at these
time points. Induced sputum was collected during screening
and 3 h post exposure. Blood was collected before, 2, 4 and
21 h post exposure.
During a screening visit a physical examination was
performed, the subject’s history taken, and a baseline
sputum induction performed. Subjects capable of
producing an adequate sputum sample (1 106 total
cells, 50% cell viability, 20% squamous epithelial cells)
underwent a screening ozone challenge and were included
into the study, if their response to ozone was a >10%
increase in the percentage of neutrophils. A follow-up visit
was scheduled within 7 days after the last exposure to
perform a physical examination, spirometry and to assess
any adverse events or concomitant medications.t 14 days apart (eNose: electronic nose, FeNO: exhaled nitric
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Fourteen healthy non-smoking subjects responsive to ozone
were included. Non-smoking was checked by urine cotinine
tests. Subjects had to be free of upper or lower respiratory
tract infection for at least 4 weeks prior to screening and
prior to each visit. Subjects with a positive skin prick test to
common aeroallergens were excluded. No regular intake of
a prescribed or over-the-counter medication other than
paracetamol for pain relief, oral contraceptive medication,
hormonal replacement therapy, or dietary and vitamin
supplements were allowed. The study was approved by the
Ethics Committee of the Hannover Medical School, and all
participants gave their written informed consent.
Exposure
Subjects were exposed in the Fraunhofer-ITEM exposure
chamber to 250 ppb ozone (O3) and to filtered room air (RA)
for 3 h with intermittent bicycle ergometer exercise
(15 min exercise alternating with 15 min rest, ventilation
rate during exercise adjusted to 20 l/min/m2 body
surface). During exposure, heart rate was monitored
continuously via ECG, and blood pressure was measured
every 30 min.
The exposure chamber (2.7 2.3 2.5 m3) was venti-
lated by conditioned air with temperature of 20e25 C and
relative humidity of 40e60%. The high purity ozone input
was generated by the method of surface discharge using
a COM ADM generator (ANSEROS GmbH, Tu¨bingen), which
was operated with 100% medical oxygen. The ozone
concentration in the exposure chamber was continuously
controlled via an ozone analyzer and controlling unit
(Ozomat MP, ANSEROS, Tu¨bingen).
The safety of exposures was ensured by built-in
maximum limits of ozone flux as well as by an independent,
monitor-type ozone analyser (400A, MLU-Messtechnik fu¨r
Luft und Umwelt GmbH, Essen) working by the principle of
UV absorption. This instrument was used to monitor the
target concentration of 250 ppb in the exposure chamber
continuously and was routinely checked by official author-
ities (TU¨V Nord Umweltschutz GmbH) using a certified
instrument.
Analysis of exhaled breath
Exhaled breath samples were analyzed by an electronic
nose (Cyranose 320, Smiths Detection, Wiesbaden,
Germany) which is based on a nanocomposite array of 32
organic polymer sensors. Exposure to VOCs induces
a swelling of the sensor polymers, leading to a change in
their electrical resistance. At each time point, at least four
separate samples were collected into four different poly-
ethylene bags for immediate analysis by the Cyranose 320.
The subjects exhaled into the bags with a single expiratory
vital capacity manoeuvre at a standardized flow rate of
0.15 L/s. This was achieved by placing the PE bag inside
a PE box, which was equipped with a release valve and
connected to a pressure sensor. The valve was adjusted to
allow a flow of 0.15 L/s at a pressure of 9 mbar, a pressure
which closes the nasal velum and excludes contaminationby air from the nasal cavities. Subjects were asked to
maintain this pressure for 10 s by observing the pressure
sensor display. Exhalations with a deviation from these
requirements were discarded. Immediately after collection
each bag was connected to Cyranose 320 for analysis.
As the sensors are sensitive to humidity and complete
drying of exhaled air without potential losses of VOCs is
virtually impossible, the baseline signal of Cyranose 320
prior to each measurement was performed with room air
that had been 100% water-saturated and showed compa-
rable temperature as the breath samples during analysis.
Subjects were asked to refrain from eating at least 2 h prior
to each collection, to drink only water in this time period
and to rinse their mouth before the collection of breath
samples.
Measurement of exhaled NO (FeNO) was performed
following the ATS/ERS-recommendations14 using a NIOX
chemiluminescence analyzer (Aerocrine, Solna, Sweden).
Measurement of CO in exhaled breath, as a potential
marker of oxidative stress, was performed with a commer-
cially available device (Smokerlyzer Microþ, Bedfont
Scientific, Rochester, UK) according to the manufacturer’s
instructions.
Induced sputum
Sputum induction was performed as previously described.15
Briefly, subjects inhaled 3, 4 and 5% hypertonic saline in
3 consecutive 5-min inhalation periods. After each period
subjects were asked to produce sputum. Sputum plugs were
selected, pooled and dispersed for 15 min in PBS. After
centrifugation, supernatants were collected and stored at
80 C before the analysis of MPO (Biovendor, Heidelberg,
Germany) and total protein (Biuret). The sputum was then
homogenised with Sputolysin (Calbiochem, Darmstadt,
Germany). After filtration, cytospins were prepared and
a differential cell count was performed by counting at least
400 non-squamous cells.
Blood biomarkers
Blood was drawn by venous puncture and serum collected
and stored at 80 C prior to the analysis of CRP (Diagnostic
Laboratory LADR, Hannover Germany), CC16 (Biovendor),
and SP-D (Biovendor) by ELISA. Blood samples were also
taken for routine differential cells count and clinical
chemistry. Total cell count was performed by AC-T8 hae-
matology analyser (Beckman Coulter) as well as by
morphological gating using flow cytometry. One aliquot of
blood was used to measure CD11bþ neutrophils by flow
cytometry. Briefly, the blood was incubated with goat serum
(20 min, 4 C) and washed prior to incubation with the
antibodies and respective isotype controls for 30 min at
4 C (CD11b-FITC, IsoIgG1-FITC (Invitrogen, Darmstadt,
Germany), CD3-FITC, CD4-PE, CD8-PE (BD, Heidelberg,
Germany), CD14-PC5 (Beckmann Coulter, Krefeld,
Germany), CD68-FITC (AN.DER.GRUB, Kaumberg, Austria)).
After washing, cells were lysed (VersaLyse-Reagenz, Beck-
man Coulter). After two further washing steps samples were
stored on ice until analysis by a Beckman Coulter Cytomics
FC500 flow cytometer.
Table 1 Subject’s characterisation.
Mean SD
Gender m/f 11/3
Weight kg 81.5 12.1
Height cm 182.6 8.3
Age years 33.1 9.5
FEV1 %Predicted 107.9 10.6
FVC %Predicted 112.0 13.8
Screening induced sputum:
Baseline NG % 42.4 20.4
104/mL 28.5 2.5
Ozone NG % 72.3 14.1
104/mL 68.2 2.8
NGZ neutrophil granulocytes (cell number expressed as
geometric mean and SD), SDZ standard deviation.
Figure 2 Median and interquartile range (IQR) of sputum
neutrophils. Left: data from the screening phase. Right:
data obtained during the study after the respective exposures
(including intermittent exercise). RA: filtered room air
(*p< 0.05).
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Non-normally distributed data was log-transformed.
Repeated measures ANOVA with NewmaneKeuls post-hoc
test was used to detect differences between exposures at
different time points. Paired t-test or Wilcoxon-matched-
pairs-test were employed for the comparison of sputum
data.
For the eNose sensor data first the mean value of up to
4 separately analyzed bags was calculated. Due to a failure
in the humidifier, and consequently a biased calibration,
3 consecutive eNose measurements (affecting 3 subjects)
had to be excluded from the analysis. To avoid a bias, all
data of these 3 subjects were excluded, limiting the anal-
ysis of eNose data to 11 subjects. As it was not a priori clear
which characteristics the data would show, different
approaches were chosen. Datasets were analyzed either as
raw/original data, or log-transformed, or standardized
(subtraction of the mean value and division by the standard
deviation of all cases), or after normalizing the sum of raw
values of all sensors of each measurement to one. The
results are shown for the original and the normalized
dataset. To determine the relationship between the
different parameters, a factor analysis was performed using
all above mentioned datasets 1) with 22 cases (including
sputum data) and 2) with 88 cases including blood,
spirometry data, and sensor data. Discriminant analysis
(DA) was used to assess whether subjects could be sepa-
rated at different time points after exposures. The rule
that DA should possibly not include repeated measurements
could not be followed in this exploratory analysis. All
statistical evaluations were performed using Statistica 8.0




Thirty-seven subjects were screened but only 15 subjects
were included into the study (16 failed to produce an
adequate baseline sputum sample, 1 did not show a suffi-
cient response to ozone, 4 due to ongoing upper respiratory
tract infection, and 1 due to abnormalities in the electro-
cardiogram). One subject had to be excluded from the
study after randomisation due to repeated upper airway
tract infections during the study. Fourteen subjects
completed all exposures and measurements and were
included into the analysis (Table 1).
Analysis of airway inflammation
All 14 subjects were able to produce adequate sputum
samples during the study. We observed an increase in
absolute numbers (pZ 0.039) and percentages (pZ 0.013)
of sputum neutrophils after O3 exposure as compared to the
exposure to RA (Fig. 2). The increased proportions of
neutrophils corresponded to lower percentages of macro-
phages (pZ 0.034). There was no difference in the level of
total protein between exposures (median (IQR) RA: 259.5(130.6) mg/L; O3: 338.6 (99.4) mg/L; pZ 0.36), but the
concentration of sputum MPO was higher after ozone
exposure (RA: 245.3 (214.6) ng/mL; O3: 432.3 (347.2) ng/
mL; pZ 0.02).
We also detected a fall in FeNO 3 h after ozone exposure
compared to RA (pZ 0.01). This also applied to the relative
change of FeNO after ozone (pre vs. 3 h post, pZ 0.004) but
not filtered air exposure. When comparing ozone and filtered
air, there was no significant effect of ozone on CO concen-
trations in exhaled air. However, compared to pre-exposure
values, CO levels were decreased 3 h (pZ 0.004) and 6 h
(pZ 0.01) afterboth, RAandO3, exposures and returnedback
to baseline at 24 h. While pre-exposure FeNO measurements
showed a good correlation with each other (Pearson’s
rZ 0.73, p< 0.003), the levels of CO showed a larger intra-
individual variability, without significant correlation.
Analysis of systemic inflammation
Compared to pre-exposure values, the number of blood
leukocytes, as well as the percentage (Fig. 3A,B) and
Figure 3 Effect of ozone on the total number of blood
leukocytes (A), the percentage of blood neutrophils (B) and the
activation of blood neutrophils (C). Median and interquartile
range (IQR). Repeated measures ANOVA (post-hoc test: New-
maneKeuls): *p< 0.05, **p< 0.01 compared to pre-exposure,
#p< 0.05, ##p< 0.01 compared to RA (filtered room air).
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O3 exposure (each p< 0.001). For all three measures the
increase was more pronounced following ozone (p< 0.01 for
all 5 h and 7 h comparisons of RA vs. O3). The percentage of
blood neutrophils was still elevated 24 h after ozone
(pZ 0.004, Fig. 3B), but absolute numbers had returned topre-exposure levels. Corresponding to the changes in the
proportions of neutrophils, inverse changeswere seen for the
proportions of monocytes, lymphocytes, and eosinophils.
The lowest numbers ofmonocytes occurred 7 h after both RA
and O3 exposure, without significant difference between
exposures. Changes in lymphocyte numbers were small, with
a decrease only 5 h and 7 h after ozone exposure (pZ 0.007
andpZ 0.0003). Numbers of blood eosinophils decreased 5 h
and 7 h after exposure and did not return to baseline after
24 h (each p< 0.001), without a significant difference
between exposures.
The total number of leukocytes determined using flow
cytometry correlated with the number determined by the
AC-T8 counter (r> 0.96 and p< 0.001, each). The propor-
tion and number of CD11b-positive neutrophils increased
both 5 h and 7 h after both RA or O3 exposure, whereby the
increase after ozone exposure was significantly larger
(p< 0.003 for all comparisons between 5 h and 7 h time
points, Fig. 3C).
CRP concentrations in serum were increased 24 h after
ozone exposure (p< 0.01 compared to pre-exposure). To
address potential effects on lung permeability, we assessed
surfactant protein D (SP-D) and Clara Cell protein 16 (CC16)
in serum. There were significant changes of serum SP-D
concentrations after both ozone and RA exposure compared
to the pre-exposure levels (5 h: p< 0.01, 7 h: p< 0.01,
24 h: p< 0.05 for both ozone and RA). While no significant
ozone effect on serum SP-D concentrations could be
detected, serum CC16 levels were increased 5 h and 7 h
after ozone (pZ 0.01, pZ 0.001) and returned to baseline
24 h after exposure (Fig. 4A,B). The correlation between
different time points for both markers was high (e.g. SP-D:
pre-exposure vs. 24 h post exposure rZ 0.96, p< 0.001;
CC16: rZ 0.85, p< 0.001, respectively). While the intra-
individual variability for SP-D was low, large differences
were observed between individual subjects (Fig. 4C).Safety
Pre-exposure lung function values were comparable. Ozone
exposure was well tolerated by all subjects. The mean (SD)
pre-O3 exposure FEV1 was 104.3 11.8% of predicted
normal. FEV1 changed to 96.7 13.8% predicted immedi-
ately after ozone exposure (p< 0.001). The respective FVC
values were 109.7 14.1 and 103.8 16.5% predicted
(p< 0.001). The maximum fall in FEV1 after O3 exposure
over all subjects was 23%. No significant effects of ozone on
FEV1 or FVC were observed in the 6 h and 24 h post expo-
sure values.Analysis of eNose breathprints
Effect of ozone exposure and time points on individual
eNose sensors
Using the original and the normalized sensor datasets there
were no statistically significant differences between expo-
sures when comparing the signals of each of the 32 sensors
individually (ANOVA). However, most of the absolute and
normalized pre-exposure sensor values were significantly
different compared to the other time points.
Figure 4 Median (IQR) serum concentrations of CC16 (A) and
SP-D (B) after ozone and RA exposure. Repeated measures
ANOVA (post-hoc test: NewmaneKeuls): *p< 0.05, **p< 0.01
compared to pre-exposure, #p< 0.05, ##p< 0.01 compared to
RA (filtered room air). (C) Interindividual difference in serum
SP-D concentrations. Median (IQR) of 8 measurements (4 time
points, 2 exposures).
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By factor analysis we extracted 3 major factors from the 32
sensors and compared the resulting values between different
exposures and time points. For the original dataset there was
only one eigenvalue >1, while 3 eigenvalues from thenormalized dataset were >1. Fig. 5 shows the data based on
the original, untransformed data (left) and the normalized
dataset (right). The factors (F ) explained 98% (96% for the
normalized dataset) of total variance (F1: 94.2% (88.1%), F2:
2.7% (4.8%) and F3: 1.4% (3.2%)). No difference between RA
and O3 exposures was detected, but F2 showed higher values
for pre-exposure as compared to post exposure measure-
ments. This pattern resembled those observed for sensors 5,
23, and 31, which strongly loaded onto F2. The separation of
the pre-exposure values was more pronounced for the
normalizeddataset, as here thedifferencewas alsopresent in
F1, which additionally explained a larger portion of the vari-
ability. A similar picture as with the original dataset was
obtained for log-transformed data, with a more pronounced
loading of sensors to F1. None of these analyses revealed
a difference between exposures.
We then used the 3 factors to assess whether in combi-
nation they would contain information on ozone-induced
differences. Principal component analysis was used with
respect to the following group assignments.
1. All post O3 vs. all pre-exposure and all post RA;
2. all pre-exposure and 24 h vs. 3 h, 6 h post RA vs. 3 h, 6 h
post O3;
3. 3 h, 6 h post O3 vs. all others;
4. 3 h post O3 vs. all others;
5. 3 h and 6 h post O3/RA vs. all pre-exposure and 24 h
post O3/RA.
For none of these comparisons a clear separation was
observed. The best separation was seen using the normal-
ized dataset and group assignment 2 (Fig. 6A). While pre-
exposure and 24 h values could be separated to a certain
extent from the 3 h and 6 h time points, the 2 major factors
were not capable of separating between RA and O3 expo-
sure. To estimate the suitability of the method, the same
analysis was used with factors derived from other param-
eters (SPD, CC16, lung function, blood differential cell
count, blood neutrophil activation) (Fig. 6B).Separation of exposures and time points by discriminant
analysis
Discriminant analysis (DA) was used as a further procedure
to assess whether a separation between the above
mentioned group assignments could be achieved. First only
the 3 extracted factors (see above) from the different
sensor datasets were used. No sufficient separation
between the above mentioned groups was achieved as the
proportion of correct classification of at least one group
within each analysis stayed below 50%. Only the factors
derived from the normalized dataset achieved a separation
>60% (group assignment 5).
Due to the high redundancy between the 32 sensors, it
was not possible to perform the DA with all sensors. When
only sensors with the highest loadings on the 3 factors were
included into model, no or only weak separation was
possible between groups 3 and 4 (see group assignments
above). For assignment 1, 85% of all post O3, 58% of all pre-
exposure and all post RA values could be classified
correctly. For assignment 2, 84% of all pre-exposure and
24 h values, 54% of all 3 h/6 h post RA and 64% of all 3 h/6 h
Figure 5 Comparison between exposures. Left column: 3 major factors extracted from the untransformed sensor dataset (32
sensors). Right column: 3 major factors extracted from the normalized sensor dataset (each measurement normalized to 1). Median
and IQR for each time point after exposure. (*p< 0.05, **p< 0.01 compared to pre-exposure).
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confirmed the separation by showing that all 3 h and 6 h
time points separated best from all pre-exposure and 24 h
time points.
Biomarkers in sputum and blood e relationship to sensor
data
A number of biomarkers in blood and functional parameters
were measured at about the time of eNose measurements
(maximal difference 1 h). To elucidate the relationship
between these values, independently from exposure or
time point, a factor analysis was performed which used the
data of all 88 assessments for which eNose, blood and
functional data were available (11 subjects, 2 exposures, 4time points, Table 2). As eNose sensor values were highly
correlated with each other, we used as variables the 3
factors extracted from the original (Table 2, left side) or
the normalized datasets (Table 2, right side) as described
above (“Sensor Factors” in Table 2).
Five factors with eigenvalues >1 were extracted for
both extended datasets, explaining approximately 71% of
variance. The explained variance of the individual factors
was very similar, mean values being 37%, 12%, 10%, 7% and
7%. Table 2 summarizes the factor loadings for both data-
sets. As expected, blood cell parameters grouped together
and showed high factor loadings on Factor 1, with opposite
signs for neutrophils and the other blood cells. Lung func-
tion parameters grouped as Factor 2. The Sensor Factors
Figure 6 Separation of all pre-exposure and 24 h values
(open circles) from all 3 h and 6 h post RA values (black circles)
and from all 3 h and 6 h post O3 values (stars). (A) Using 2 major
factors derived from the normalized sensor dataset. (B) Using
factors derived from non-sensor parameters (SPD, CC16, lung
function, blood differential cell count, blood neutrophil
activation).
Breath profiles correlate with systemic markers 1359grouped together with the level of SP-D in serum and with
blood cell parameters. For the normalized dataset the
relationship of Sensor Factors to serum SP-D was not as
obvious, and Sensor Factor 2 grouped together with exhaled
NO. In summary, the factor analysis shown in Table 2
basically yielded two results: firstly, the expected close
relationship between blood markers as well as between
lung function parameters, suggesting the validity of the
analysis, secondly hints towards a so far not recognized
relationship between sensor data and systemic markers (SP-
D and blood cell composition).
Based on these results we looked into the relationships in
more detail. In fact serum SP-D correlated with the major
factor of the sensor data (Sensor Factor 1, rZ 0.39, p< 0.001)
as well as with the individual sensors (all r> 0.46 and
p< 0.001). Sensor Factor 2 showed a correlation with blood
neutrophil proportions and numbers (rZ0.56, rZ 0.54, both
p< 0.001), but the correlation with the individual sensor data
was weaker (rZ 0.2e0.5, all p< 0.05, except sensor 22). The
correlation coefficients for the relationship to the other
blood cell markers highlighted in Table 2 were close to 0.5 or
below. With the normalized dataset, increased correlationcoefficients for Sensor Factor 1 and blood cell markers
(neutrophils: Fig. 7), and decreased coefficients for the rela-
tionship between sensors and serum SP-D were observed,
confirming the data of the factor analysis. There was no
correlation between Sensor Factor 2 and FeNO.
No correlations between sputum neutrophils, protein
and MPO levels and the sensor data were found. Due to the
fact that sputum was only available at one time point, this
comparison was limited to a total of 22 cases. The results
using the standardized and the log-transformed dataset
were similar and are not shown.Discussion
Employing the well-characterized ozone challenge model we
showed ozone-induced inflammatory responses both in
sputumand inblood of healthy volunteer subjects. No specific
change in volatile breathprints, as measured by a 32 polymer
sensor electronic nose (Cyranose 320), occurred after ozone
exposure. However, independently from exposures eNose
sensor valueswere correlatedwithbloodneutrophils andwith
serum levels of SP-D, a protein produced mainly by type II
pneumocytes and potential marker of lung permeability. This
result supports the hypothesis that at least VOCs of systemic
origin canbedetectedby theCyranose320.However neither
the composition nor the mechanisms determining the trans-
port of the respective VOCs into the exhaled air are known.
Irrespective of this, our study provides clues, that exhaled
breath profiles are related to blood cell composition or lung
permeability even in healthy subjects.
Experimental ozone exposure is known to cause transient
airway inflammation which is primarily characterized by
a neutrophil influx into the airways.16 Both the lung function
response17 and the inflammatory response to ozone are
reproducible,16 and the ozone challenge can beused as a tool
to test anti-inflammatory drugs early in development.11 The
effect on sputum neutrophils observed in our study is fully in
line with previously published results11e13 and demonstrates
the reliability of the model. This robustness seems to apply
also to blood biomarkers, as the effect on the serum levels of
CC16 and SP-D has also been observed previously.12
Regarding the activation of blood neutrophils, we detected
the upregulation of CD11b-expression after ozone exposure,
which corresponds to the influx of neutrophils into the
airways and increased sputum levels of MPO. Overall, the
ozone challenge performed in our study caused the expected
airway and systemic responses.
A control exposure with filtered air is not common, when
the ozone challenge model is applied to test novel anti-
inflammatory compounds. The same is true for the deter-
mination of the kinetics of blood biomarkers. We collected
blood samples before, 5 h, 7 h and 24 h after exposure. This
approach revealed that even after exposure to room air
blood leukocyte, especially neutrophil, numbers signifi-
cantly increased which was accompanied by an increase in
CD11b-expression. As the RA and O3 exposure conditions
were comparable except for the presence of ozone, this
effect was probably due to the exercise, which is known to
be indispensible in order to increase ventilation and ach-
ieve measurable responses to ozone. This observation
indicates that one should be careful in attributing biological
Table 2 Results of factor analysis.
Five major factors were extracted from all non-sensor variables listed in the left column and from the factors values previously
extracted from the sensor datasets (here listed as “Sensor Factors”, which were either extracted from untransformed (original), or
normalized sensor datasets, as indicated). Factor loadings (which indicate the extent of correlation between factor and variable) that
exceed 0.5 or 0.5 are printed in bold to indicate which parameters group together (CCZ cell count, WBCZwhite blood cells).
1360 H. Biller et al.responses to ozone only. Exercise might also have been
responsible for the increased number of sputum neutrophils
after RA exposure compared to screening.
The concentration of exhaled nitric oxide (FeNO)
was decreased 3 h after ozone exposure. As ozone does
not induce significant bronchoconstriction, but a transientFigure 7 Correlation between blood neutrophils (%) and the
major factor extracted from the normalized sensor dataset.
Data of all exposures and time points is included (rZ 0.47,
p< 0.001).restriction-type lung function response, this cannot be
explained by a reduction of bronchial surface area, as for
methacholine or allergen challenges.18 More likely expla-
nations are an increase in the amount of surface liquid19 or
the production of reactive oxygen species after ozone
exposure, as highly reactive molecules could scavange NO
molecules.20
No difference between exposures was observed for
exhaled CO, but values were lowered 3 h and 6 h after both
RA and ozone exposures. A decline after exercise has been
reported for athletes.21 As the exhaled CO comes from the
vascular system, changes in lung diffusing capacity during
exercise could be of importance. The fall in exhaled CO
levels has been attributed to an increased diffusing
capacity for CO during exercise, but this would apply to
local CO production and increased uptake in the lung. In
contrast, an increased diffusing capacity should result in
higher exhaled CO values from systemic sources. In fact, for
a number of compounds, such as isoprene, acetone, methyl
acetate22 and ethanol21 increased concentrations during
exercise have been reported, the latter concentrations
returning to baseline 30 min after exercise.21 For most
other compounds it is not known how long potential effects
last after exercise. It is most likely that the fall in CO levels
and the subsequent rise after 24 h simply reflected the
clean air conditions of the exposure.
Using the ozone challenge model, a change in airway and
systemic inflammation could be detected in blood and in
Breath profiles correlate with systemic markers 1361induced sputum, while there was no difference in the VOC
breath print pattern between ozone and RA exposure. This
was true despite the fact, that we found a relationship of
eNose sensor signals with the level of blood neutrophils
(Fig. 7), which increased after ozone. This discrepancy
reflects the rather low correlation between eNose sensor
signals and blood neutrophils. Although statistically signif-
icant when evaluated over all measured values, the rela-
tionship was too weak to resolve differences at specific
time points between exposures.
Higher correlation coefficients were found for the rela-
tionship of eNose sensor signals to the serum concentration
of SP-D. SP-D showed little intraindividual variation, while
large interindividual differences existed even in the healthy
subjects (Fig. 4C). The serum SP-D levels were not acutely
affected by ozone exposure; they are known to be
increased in smokers and patients with COPD.23 As the
major source of SP-D seems to be the type II pneumocyte of
the lung, it could be a potential biomarker for lung damage
in COPD. Very little is known so far, how, and even if, SP-D
translocates in detectable amounts from the lung to the
blood. Which VOCs are altered in subjects with high serum
SP-D levels are also unknown. Despite this, the correlation
of the nonspecific sensor signals with an identifiable
systemic marker seems of great interest.
There are several factors that could explain why ozone-
induced changes were not observed with the Cyranose 320.
It is unknown, whether ozone actually causes a change in the
pattern of exhaled volatile compounds, and whether these
changes are strong enough to be detected by the Cyranose
320, which is not among the most sensitive devices. While
our studywas sufficiently powered to detect the neutrophilic
response to ozone in sputum, larger sample sizes might be
required for the assessment of VOC in exhaled air as primary
outcome. “Relative unpolar carbonyls” have been found to
be elevated in breath samples of subjects undergoing an
ozone challenge (400 ppb, 2 h). These, however, were
detected after pre-concentration of 20 L of exhaled breath
and by an HPLCmethodwith UV detection; the report did not
provide quantitative data.24
The most common VOCs of the breath of healthy subjects
show concentrations of 1e100 ppb, with ethanol, methanol
and isoprene generally ranging between 100 and 500 ppb and
acetone reaching peak concentration of more than
2500 ppb.25,26 Most other compounds are likely to occur in
lower ppb ranges.27 The detection limit of the Cyranose 320
has not been precisely documented, and due to the use of
polymer sensors it will vary for different VOC compositions.
Laboratory measurements with defined VOC concentrations
(datanot shown) suggest that the Cyranose 320 is sensitive in
the ppm range, which limits the number of compounds that
are detectable in human breath samples. Probably only
compounds originating from the alveoli and systemic circu-
lation will reach this concentration range. The fact that the
Cyranose 320 could separate breathprints of patients with
asthma and COPD,8 or COPD and lung tumour,28 suggests this
was due to differences in systemic compounds. Differences in
systemic factors would be fully in line with our present
findings.
As we collected breath samples before and at three
different time points up to 24 h after ozone exposure, it
seems unlikely that we have missed a signal. The fact thatduring this time period most markers returned to baseline
also argues against this possibility. A technical failure of the
cyranose is also unlikely. In particular, the device clearly
picked up the signal from a contaminated water bath for
humidification of the reference (resulting in the exclusion
of 3 subjects as mentioned above).
An important issue is thebreath sampling. EvenTedlarbags
are not reliable over longer time periods, as water vapour
diffuses out of the bags within minutes, while acetone, often
found in the ambient air, can diffuse into the bags.29 We used
fresh untreated polyethylene bags in our study, and samples
were analyzed within 1 min after collection.
So far only few laboratories evaluate the Cyranose 320
for clinical applications, and the procedures are far from
being standardized. This refers to the way breath samples
are collected, the internal settings and calibration of the
instrument, and to data processing statistical analysis. As
the sensors are very sensitive to humidity, the analysis of
breath samples of 100% humidity at room temperature
depends on the treatment of the sample and the reference
taken. There are basically two approaches. In two pub-
lished studies the exhaled air was partially dried8,30 by
exhalation through a silicagel filter. The remaining humidity
ranges between 30 and 40% (Fens et al., personal commu-
nication). As humidity is the by far dominant part of the
signal, even small changes in humidity will affect the sensor
signal to the same extent as a large change in VOC. The
idea to remove this effect by normalization of the sensor
signals, implicitly assumes that the sensors respond pro-
portionally to each other to humidity, which is not the case
(data not shown). Therefore we chose the approach of
humidifying the reference air to 100% humidity at room
temperature, i.e. the same conditions as for the breath
sample. While we cannot exclude that this affected the
response to VOCs, it had the great advantage, to control
physically e and not only numerically, under unjustified
assumptions e for the dominant effect of water vapour. We
therefore preferred this approach.
Upon extracting the major statistical factors from the
sensor data, we noted that pre-exposure values were
different from sensor data obtained 3, 6, and 24 h after
exposures. A detailed analysis revealed that this was most
likely due to the fact that pre-exposure measurements
were generally performed first in the morning. The Cyra-
nose 320 was therefore running for longer periods of time
before the other measurements, including the 24-h values,
as pre-exposure measurements were done up to 2 h prior to
the start of the exposure. The cyranose comprises an
internal temperature sensor, which showed lower temper-
atures (32e35 C) in the morning than at the other time
points (34e37 C). Even these small temperature differ-
ences probably caused the differences in sensor signals in
the pre-exposure levels, as it is known that sensitivity
decreases with sensor temperature and this effect can
differ between sensors within the array.
We did not use VOC filters to scrub the air that subjects
inhaled prior to measurements. The usefulness of this is
doubtful, as VOC in the body are stored in the fat tissue and
only slowly released. A potential bias by VOCs inhaled hours
or days before breath sampling cannot be excluded. More
importantly, one might even worsen the situation by
removing VOCs within a limited period of time in an
1362 H. Biller et al.undefined manner. Therefore we considered it best to let
the subjects inhale room air and to use humidified room air
as a reference in order to make both air samples as similar
as possible with regard to all potential artefacts, in
particular humidity and VOCs from the present ambient air.
Finally the type of data analysis chosen can have
profound effects on the final results. In this exploratory
study we used several approaches to analyse the data, as
there was no sufficient prior information on the most
appropriate procedure. Moreover, the properties of the
dataset were not completely covered by a single proce-
dure. We not only used the original eNose sensor dataset,
but also log-transformed, standardized and normalized
datasets. None of these revealed a significant difference
between ozone and control exposure, but all indicated the
relationship of sensor signal with neutrophils and SP-D; this
finding seemed to be fairly robust and not critically
dependent on a specific type of data processing.
Factor analysis and principal component analysis were
employed to assess whether exposures or time points
would show differences when condensing the high-
dimensional information of the data to lower-dimensional
measures. Additionally discriminant analysis was applied
to achieve the optimal discrimination between exposures.
Using the different datasets and methods, we did not
detect a significant exposure effect. The validity of the
various approaches was indirectly supported by the fact
that inclusion of blood biomarkers or functional data into
the analysis resulted in a clear separation between
exposures.
Conclusions
In summary, our data indicate that even by using a careful
methodological approach and advanced methods of statis-
tical analysis it was not possible to detect the inflammatory
response to ozone by the eNose Cyranose 320 in healthy
subjects. On the other hand, sputum analysis clearly indi-
cated the neutrophilic response. Interestingly, there was
an overall correlation between eNose signals and blood
neutrophils, indicating a relationship between eNose sig-
nals and systemic factors across subjects, as well as
a relationship between sensor data and serum SP-D. Our
data appear to discourage the use of this electronic nose
device, at least in its current form, as a non-invasive tool
to specifically detect neutrophilic airway inflammation in
the challenge model used but they encourage its clinical
use owing to the relationships to systemic markers.
The study also underlines that future research has to
address a number of methodological issues, such as the
standardization of sampling for maximum sensitivity and
comparability and the influence of humidity.
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